Arcutis Biotherapeutics News and Activities

Arcutis Biotherapeutics is one of the...

• Russell 3000;
• TOB Iconic 10,000.

Arcutis Biotherapeutics is a company listed under the stock ticker ARQT (US).

View the org chart displaying its 41 main executives

Most searched biographies at Arcutis Biotherapeutics

• Frank Watanabe, Director, President and Chief Executive Officer
• Halley Gilbert, Director
• Howard Welgus, Director

Popular executive movements at Arcutis Biotherapeutics

• Amit Munshi has joined the company as Director  (posted on December 10 2025).
• Bhaskar Chaudhuri, Director, is retiring  (posted on December 10 2025).

Create your alert
to follow the executive moves at Arcutis Biotherapeutics.

Arcutis Biotherapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Arcutis Biotherapeutics

Social media about Arcutis Biotherapeutics

• Arcutis Biotherapeutics on Wikipedia, Google News & Yahoo Finance
• Arcutis Biotherapeutics on LinkedIn, X (Twitter) & YouTube